Anas Hadeh, MD
Pulmonary Disease · Weston, FLNPI 1437360187
Payments from drug & device makers
Across 941 payments — averaging $896.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$408K
- Insmed, Inc.$165K
- AstraZeneca$110K
- Sanofi$63K
- Mannkind Corporation$28K
- Grifols USA, LLC$26K
- plus $44K from 32 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 358 | $408,025 |
| Insmed, Inc. | 225 | $165,120 |
| AstraZeneca | 140 | $109,654 |
| Sanofi | 48 | $62,841 |
| Mannkind Corporation | 4 | $28,132 |
| Grifols USA, LLC | 20 | $25,794 |
| Grifols Shared Services North America, Inc. | 9 | $9,142 |
| Verona Pharma, Inc. | 9 | $9,066 |
| Chiesi USA, Inc. | 5 | $8,600 |
| Regeneron Healthcare Solutions, Inc. | 8 | $4,244 |
| Boehringer Ingelheim | 23 | $4,193 |
| Nabriva Therapeutics, PLC | 2 | $1,784 |
| Boehringer Ingelheim International GmbH | 16 | $1,692 |
| Merck | 2 | $1,502 |
| Inari Medical, Inc. | 4 | $690 |
| Actelion Pharmaceuticals US, Inc. | 9 | $509 |
| Genentech USA, Inc. | 5 | $406 |
| United Therapeutics Corporation | 8 | $400 |
| Baxter Healthcare | 5 | $228 |
| Mylan Specialty L.p. | 5 | $220 |
| Advanced Respiratory, Inc | 3 | $207 |
| Inspire Medical Systems, Inc. | 3 | $200 |
| Pulmonx Corporation | 2 | $164 |
| Mallinckrodt Enterprises LLC | 3 | $146 |
| Pharming Healthcare, Inc. | 1 | $125 |
| Amgen | 1 | $123 |
| Bayer | 1 | $109 |
| Mallinckrodt Hospital Products Inc. | 4 | $96 |
| Novartis | 5 | $79 |
| Philips North America LLC | 3 | $47 |
| AbbVie | 2 | $43 |
| Lungpacer Medical USA Inc | 1 | $31 |
| ERBE USA Inc | 2 | $25 |
| BD | 1 | $20 |
| Gilead | 1 | $19 |
| Ambu Inc. | 1 | $18 |
| Circassia Inc. | 1 | $18 |
| Pinnacle Biologics, Inc | 1 | $14 |
How this compares
$843,725 in reported general payments places this provider in the 95th percentile of 953 pulmonary disease providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Weston
- Franck RahaghiWeston$1.5M
- Jinesh MehtaWeston$645K
- James KrainsonMiami$11.7M
- Jose DiazLeesburg$11.2M
- Carlos MartinezHomestead$9.2M
- Leonard DunnDunedin$7.6M
- Francis AverillClearwater$6.3M
- Charles BurgerJacksonville$5.6M
- Daniel LorchBrandon$5.5M
- Lourdes BoschMiami$4.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.